Jump to Main Content
Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system
- Santi, L., Giritch, A., Roy, C.J., Marillonnet, S., Klimyuk, V., Gleba, Y., Webb, R., Arntzen, C.J., Mason, H.S.
- Proceedings of the National Academy of Sciences of the United States of America 2006 v.103 no.4 pp. 861-866
- Nicotiana benthamiana, transgenic plants, gene expression, genetic transformation, plasmid vectors, synthetic genes, nucleotide sequences, Yersinia pestis, bacterial antigens, recombinant vaccines, subunit vaccines, recombinant antigens, vaccination, antibody formation, guinea pigs, biopharmaceuticals
- Plague is still an endemic disease in different regions of the world. Increasing reports of incidence, the discovery of antibiotic resistance strains, and concern about a potential use of the causative bacteria Yersinia pestis as an agent of biological warfare have highlighted the need for a safe, efficacious, and rapidly producible vaccine. The use of F1 and V antigens and the derived protein fusion F1-V has shown great potential as a protective vaccine in animal studies. Plants have been extensively studied for the production of pharmaceutical proteins as an inexpensive and scalable alternative to common expression systems. In the current study the recombinant plague antigens F1, V, and fusion protein F1-V were produced by transient expression in Nicotiana benthamiana by using a deconstructed tobacco mosaic virus-based system that allowed very rapid and extremely high levels of expression. All of the plant-derived purified antigens, administered s.c. to guinea pigs, generated systemic immune responses and provided protection against an aerosol challenge of virulent Y. pestis.